| |
|
|
|
Aridis Pharmaceuticals Inc  
|
|
6.89 -0.12 (-0.02%) |
01-22 16:00 |
|
Open: |
7.02 |
Pre close: |
7.01 |
Target:
|
8.75 
|
|
High: |
7.25 |
Low: |
6.89 |
Resistance:
|
7.49
8.75
|
|
Volume: |
18,112 |
Market Cap: |
69M |
Support:
|
6.45
5.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.07
|
MACD |
MACD(12,26):
|
0.10 |
|
MA(20): |
6.54  |
Signal(12,26,9): |
0.01 |
|
MA(100): |
6.98 |
Stochastic Oscillator |
%K(14,3):
|
73.96 |
|
MA(250): |
6.80 |
%D(3): |
81.31 |
|
Average Volume(K) |
3-Month: |
1280
|
52-Week |
High:
|
10.18 |
|
10-Days: |
1801 |
Low: |
3.80 |
|
RSI |
RSI(14):
|
53.80 |
Change(%): |
1.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.480 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
10.07 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-59.9 |
Shares Float (M) |
6.34 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
37.03 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.84 |
|
Forward EPS |
-3.510 |
Gross Profit (p.s.) |
-2.290 |
Shares Short (K) |
6 |
|
Book Value (p.s.) |
-1.270 |
EBITDA (p.s.) |
-2.178 |
P/E |
-2.78 |
|
Sales Per Share |
0.099 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-5.43 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.71 |
P/S |
69.38 |
|
Operating Margin |
-2226.70 |
Levered Free Cash Flow
(M) |
7.33 |
P/CF |
-5.93 |
|
|
|
|
|
|
